Ascendis Health Limited

JSE:ASC Stock Report

Market Cap: R450.5m

Ascendis Health Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ascendis Health.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth19.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding

Sep 23
There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ascendis Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

JSE:ASC - Analysts future estimates and past financials data (ZAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241,47242-54-8N/A
3/31/20241,484-4-45-4N/A
12/31/20231,496-51-36-1N/A
9/30/20231,516-168-106-71N/A
6/30/20231,535-286-176-140N/A
3/31/20231,547-277-228-183N/A
12/31/20221,559-268-280-226N/A
9/30/20221,559-513-215-160N/A
6/30/20221,559-759-149-94N/A
3/31/20221,833-1,211146188N/A
12/31/20212,107-1,663442469N/A
9/30/20211,966-1,677537558N/A
6/30/20211,825-1,691631646N/A
3/31/2021761-1,985555528N/A
12/31/2020-304-2,280480410N/A
9/30/2020949-1,896329318N/A
6/30/20202,203-1,512179225N/A
3/31/20205,761-1,372-21766N/A
12/31/20195,417-1,884-356-92N/A
9/30/20195,644-1,836-29252N/A
6/30/20195,872-1,788-228197N/A
3/31/20195,494-912131499N/A
12/31/20185,116-36489801N/A
9/30/20185,313-1457721N/A
6/30/20185,51134425640N/A
12/31/20177,152406N/A268N/A
9/30/20176,780373N/A324N/A
6/30/20176,409340N/A380N/A
12/31/20165,154204N/A-482N/A
9/30/20164,534181N/A-494N/A
6/30/20163,914159N/A-506N/A
3/31/20163,636204N/A-143N/A
12/31/20153,354253N/A220N/A
9/30/20153,085231N/A157N/A
6/30/20152,817210N/A94N/A
12/31/20142,289171N/A236N/A
9/30/20141,954154N/A168N/A
6/30/20141,618136N/A101N/A
12/31/201395068N/A-62N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ASC's forecast earnings growth is above the savings rate (9.7%).

Earnings vs Market: Insufficient data to determine if ASC's earnings are forecast to grow faster than the ZA market

High Growth Earnings: Insufficient data to determine if ASC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ASC's revenue is forecast to grow faster than the ZA market.

High Growth Revenue: Insufficient data to determine if ASC's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ASC's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y